AI assistant
Sending…
CATALYST PHARMACEUTICALS, INC. — Director's Dealing 2018
Jan 4, 2018
31542_dirs_2018-01-04_95af8528-484b-4b90-83f5-283c24d05166.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: CATALYST PHARMACEUTICALS, INC. (CPRX)
CIK: 0001369568
Period of Report: 2018-01-02
Reporting Person: Daly Richard J (Director)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2018-01-02 | Options to purchase common stock | $4.01 | A | 20000 | Acquired | 2025-01-02 | Common Stock (20000) | Direct |
| 2018-01-02 | Options to purchase common stock | $4.01 | A | 20000 | Acquired | 2025-01-02 | Common Stock (20000) | Direct |
More from CATALYST PHARMACEUTICALS, INC.
M&A Activity
2026
Jun 8
Report Publication Announcement
2026
May 11
M&A Activity
2026
May 7
Major Shareholding Notification
2026
Mar 26
Earnings Release
2026
Feb 25
Annual Report
2026
Feb 25
Director's Dealing
2026
Feb 19
Investor Presentation
2026
Jan 12
Director's Dealing
2026
Jan 6
Director's Dealing
2026
Jan 6